20 YEARS OF PROFESSIONAL & DEDICATED SERVICE TO GLOBAL CUSTOMERS

Custom Manufacturing, Project Outsourcing, your Trusted Partner from China

Exploring the Mechanism of Action: How ACY-738 Works as an HDAC6 Inhibitor

Understanding the precise mechanism of action for research compounds is fundamental to unlocking their therapeutic potential. ACY-738 functions as a potent and selective inhibitor of Histone Deacetylase 6 (HDAC6), an enzyme that plays a critical role in regulating cellular processes through protein deacetylation. Specifically, HDAC6 deacetylates proteins like α-tubulin, which is crucial for maintaining microtubule stability and cellular structure. By inhibiting HDAC6, ACY-738 leads to an increase in the acetylation of α-tubulin and other proteins. This modulation of protein acetylation can have profound effects on cellular functions, including cell motility, protein trafficking, and stress response.

The selectivity of ACY-738 is a key aspect of its mechanism of action. While it inhibits HDAC6 with high potency (IC50 = 1.7 nM), it shows considerably less activity against other HDAC isoforms, such as HDAC1, HDAC2, and HDAC3. This targeted inhibition is advantageous for therapeutic applications, as it minimizes the risk of off-target effects associated with broader HDAC inhibition. The implications of this selective action are far-reaching, influencing areas from neurological health to inflammatory responses. Researchers are actively investigating ACY-738 anxiolytic antidepressant effects, which may be linked to its influence on neuronal plasticity and function through protein acetylation.

In vivo studies have further elucidated ACY-738's mechanism, showing increased α-tubulin acetylation in mouse brains. This correlates with observed improvements in motor activity and behavioral responses indicative of anxiolytic and antidepressant-like effects. Furthermore, its application in models of peripheral neuropathy demonstrates its ability to protect nerve function and reduce pain hypersensitivity, likely by restoring normal acetylation levels in damaged nerves. The compound's impact on inflammatory markers and disease progression in models of conditions like polycystic liver disease also points to a complex interplay with cellular signaling pathways. As a leading supplier in China, we provide researchers with ACY-738 to enable detailed investigations into its precise mechanism of action and its diverse therapeutic applications.

Manufacturing Facilities

NINGBO INNO PHARMCHEM CO.,LTD. was established in 2007. It is committed to the R&D, production and sales of raw materials, pharmaceutical intermediates and fine chemicals. We striving to create a high-efficiency and high-quality integrated chemical service platform to better serve domestic and foreign customers.

Professional Export Experience

to Global Customers

WHY CHOSE US?

1. 20 years of R&D, manufacturing and sales experience, serving customers in 60 countries and regions around the world;

2. Own R&D laboratory, pilot platform and large-scale production workshop, which can meet the audit requirements of global customers;

3. We can satisfy customers' perfect transition from small scale lab requirements (gram level) to commercialization requirements (hundred tons level).

FAQ

  • A: We don't have Minimum Order Quantity, exact quantity should be provided before quotation for us to calculate the exact cost.

  • A: We don't provide free samples due to lots of request and expensive international courier's cost, we can deduct the sample charge after commercial order placed.

  • A: Our payment terms: Small or sample order: T/T IN ADVANCE. Commercial order: First order should be by T/T IN ADVANCE or L/C at sight, and following orders T/T 30~90days is acceptable subject to approval of credit application.

CONTACT US
Should you need to contact us; you may call during regular business hours, Monday through Friday, 8am – 6 pm.
NINGBO INNO PHARMCHEM CO.,LTD.
Address: No.163 Ruiqing Rd.,Ningbo 315000 China
Phone: 86-574-87319282
Fax: 86-574-27912196
SEND US AN EMAIL

NAME*

EMAIL*

COMPANY

COUNTRY*

MESSAGE*

Previous: The Chemical Synthesis and Supply of ACY-738: A Partner for Innovation

Next: The Therapeutic Potential of ACY-738: From Bench to Bedside

All Rights Reserved